The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AEterna Zentaris Inc closed at $0.12.

Although unchanged over the last five days, shares are down 82.61% for the last year to date. This security has underperformed the S&P TSX by 81.24% during the last year.

Key company metrics

  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield--
  • Trailing EPS-$0.54
Updated at previous session's close. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
-11,536.66%

AEterna Zentaris Inc has a net profit margin of -11,536.66%. Besides being negative, it is also below the industry average and implies that this company is not effective at turning revenues into bottom line profit.
Company Books

S&P TSX0.04%Sector:HealthcareIndustry:Biotechnology
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2015Q1/2015Q4/2014Q3/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201506/30/2015Mar 31, 201503/31/2015Dec 31, 201412/31/2014Sep 30, 201409/30/2014
Revenue0000
Total other revenue--------
Total revenue0000
Gross profit----00
Total cost of revenue----00
Total operating expense8101110
Selling / general / administrative4554
Research & development4466
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income-8-10-11-10
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax-15-104-12
Income after tax-15-104-12
Income tax, total----00
Net income-15-104-11
Total adjustments to net income--------
Net income before extra. items-15-104-12
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-15-104-12
Inc. avail. to common incl. extra. items-15-104-11
Diluted net income-15-104-11
Dilution adjustment--000
Diluted weighted average shares111726559
Diluted EPS excluding extraordinary itemsvalue per share-0.14-0.130.06-0.20
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share-0.14-0.130.06-0.20